inflammatory bowel disease
Information
- Disease name
- inflammatory bowel disease
- Disease ID
- DOID:0050589
- Description
- "An intestinal disease characterized by inflammation located in all parts of digestive tract." [url:http\://en.wikipedia.org/wiki/Inflammatory_bowel_disease, url:http\://www.mayoclinic.org/diseases-conditions/inflammatory-bowel-disease/basics/definition/con-20034908]
Disease area statistics
Chromosome band
| Gene symbol | Chromosome | Start | Stop | The number of variant |
|---|---|---|---|---|
| SLCO2A1 | 3 | 133,932,701 | 134,029,925 | 8 |
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT03985800 | Active, not recruiting | N/A | Specialty Medical Homes to Improve Outcomes for Patients With IBD and Behavioral Health Conditions | July 1, 2019 | September 30, 2026 |
| NCT02134054 | Active, not recruiting | Stavanger IBD Study - Cross Sectional | April 2014 | December 2024 | |
| NCT06031038 | Active, not recruiting | N/A | Impact of Telemonitoring in the Management of Complex IBD in Spain: M-TECCU | July 1, 2020 | April 30, 2024 |
| NCT01169207 | Active, not recruiting | Johns Hopkins Crohn's Disease and Ulcerative Colitis Study | July 1996 | December 2027 | |
| NCT00065065 | Completed | Phase 2 | A Trial of Rosiglitazone for Ulcerative Colitis | September 2002 | January 2008 |
| NCT00073047 | Completed | Phase 2 | Humanized Anti-IL-2 Receptor Monoclonal Antibody in Moderate-to-severe Ulcerative Colitis | April 2003 | July 2006 |
| NCT00167882 | Completed | Phase 4 | The Influence of 5-Aminosalicylates on Thiopurine Metabolite Levels | July 2005 | August 2006 |
| NCT00175292 | Completed | Phase 3 | A Randomized Controlled Trial of VSL#3 for the Prevention of Endoscopic Recurrence Following Surgery for Crohn's Disease. | December 2003 | |
| NCT00179439 | Completed | NPDT Evaluation in Children With CFTR and (PSC) | January 2004 | January 2006 | |
| NCT00215020 | Completed | Evaluation of Urinary Isoprostanes in the Assessment of Children With Inflammatory Bowel Disease | September 2003 | June 2006 | |
| NCT00232258 | Completed | Phase 2 | Nolpitantium Besylate In Patients With Ulcerative Colitis a Double-Blind, Placebo Controlled Efficacy and Safety Study | April 2005 | September 2006 |
| NCT00237055 | Completed | Infectious Agents in Pediatric Crohn's | August 2004 | September 2006 | |
| NCT00248742 | Completed | N/A | Psychobiology in Inflammatory Bowel Disease(IBD) | February 2001 | December 2006 |
| NCT05107492 | Completed | Phase 1 | Evaluation of the Pharmacokinetics, Safety and Tolerability of Single Dose of PF-06480605 in Chinese Healthy Participants | November 19, 2021 | April 9, 2022 |
| NCT00321412 | Completed | Phase 3 | Safety and Efficacy of AST-120 in Mild to Moderate Crohn's Patients With Fistulas | March 2006 | September 2008 |
| NCT00340444 | Completed | Genetic Studies of Inflammatory Bowel Disease | November 6, 2003 | September 19, 2007 | |
| NCT00343642 | Completed | Phase 1/Phase 2 | Dietary Treatment of Crohn's Disease | September 2006 | October 2012 |
| NCT00353639 | Completed | Telomere Repair Gene Mutation in Inflammatory Bowel Disease | May 15, 2006 | May 21, 2020 | |
| NCT00392951 | Completed | Phase 1/Phase 2 | Sirolimus for Autoimmune Disease of Blood Cells | December 2006 | February 2016 |
| NCT00408174 | Completed | Phase 3 | Balsalazide Disodium vs. Mesalamine in Mildly to Moderately Active Ulcerative Colitis | May 2006 | November 2007 |
| NCT04191707 | Completed | Metabolomic Markers of Fatigue in Inflammatory Bowel Disease | November 1, 2013 | December 1, 2019 | |
| NCT00438711 | Completed | Surgical Decision Making Among People With Inflammatory Bowel Disease | September 2005 | December 2008 | |
| NCT00446238 | Completed | N/A | Treatment of Depressed Adolescents With Physical Illness | September 2002 | August 2007 |
| NCT00486031 | Completed | Phase 3 | Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study | October 2006 | December 2008 |
| NCT00534911 | Completed | N/A | Reducing Depressive Symptoms in Physically Ill Youth | September 2007 | December 2019 |
| NCT00567593 | Completed | Phase 4 | Gene Regulation by Thiazolidinediones | October 2007 | March 2008 |
| NCT00574028 | Completed | Inflammatory Bowel Disease Research Registry | August 2007 | April 2014 | |
| NCT00577538 | Completed | Prevalence of Lymphoma in IBD | April 2006 | October 2008 | |
| NCT00577928 | Completed | Value of Fecal Calprotectin | April 2006 | December 2011 | |
| NCT00586599 | Completed | N/A | Levels of the Stat4 Alpha and Stat4 Beta Isoforms in PBMCs From Patients With Crohn's Disease and Ulcerative Colitis | August 2007 | July 2014 |
| NCT00620126 | Completed | Phase 3 | The Home Telemanagement (UC HAT) Trial for Patients With Ulcerative Colitis | January 2008 | February 2010 |
| NCT03981939 | Completed | Perianal Fistula (PAF) Validation and Burden of Illness Study | July 2, 2019 | December 31, 2019 | |
| NCT00658827 | Completed | Analysis of Birth Outcomes of Swedish, Danish and Finnish Women Exposed to Remicade With Inflammatory Bowel Disease, Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, and Psoriasis | January 1, 2007 | September 30, 2016 | |
| NCT00679003 | Completed | N/A | Managing Inflammatory Bowel Disease | September 2007 | March 2014 |
| NCT00723840 | Completed | Assessment of the Social Cost of Crohn's Disease: Economic and Quality of Life Aspects (Study P04560) | September 2006 | December 2009 | |
| NCT00727636 | Completed | N/A | Immunogenicity to Human Papillomavirus Vaccine (Gardasil) Among IBD Patients on Immunosuppressive Therapy | July 2008 | April 2011 |
| NCT00734331 | Completed | Micro Ribonucleic Acid (RNA) as Cholinergic Tone and Inflammatory Regulator in Inflammatory Bowel Disease | September 2008 | September 2009 | |
| NCT00742781 | Completed | Phase 1 | Vitamin D Supplementation in Crohn's Patients | May 2009 | December 2011 |
| NCT00746395 | Completed | Phase 4 | Randomized, Placebo-controlled Trial of Lubiprostone as a Preparation for Capsule Endoscopy | April 2008 | September 2008 |
| NCT00769353 | Completed | N/A | Understanding and Treating Neuropsychiatric Symptoms of Pediatric Physical Illness | January 2008 | January 2014 |
| NCT03881436 | Completed | N/A | Assessment of MRI Tractography for Pelvic Floor Sphincter Analysis | August 12, 2019 | August 12, 2021 |
| NCT00791557 | Completed | N/A | Open Label Study for Adults With Pyoderma Gangrenosum and Inflammatory Bowel Disease | October 2008 | February 2010 |
| NCT00798642 | Completed | N/A | Ulcerative Colitis Relapse Prevention Trial, Hypnosis | July 2007 | June 2012 |
| NCT03555617 | Completed | Phase 1 | Food-effect, Drug-Drug Interaction (DDI), and Formulation Bridging Study | June 13, 2018 | July 15, 2018 |
| NCT00810004 | Completed | Phase 3 | Maintenance Treatment of Iron Deficiency in IBD Patients | February 2009 | October 2010 |
| NCT00810030 | Completed | Phase 3 | FERINJECT for Correction of Anaemia in IBD Patients, FER-IBD-COR | October 2008 | April 2010 |
| NCT00829595 | Completed | N/A | Pneumococcal Vaccination in Patients With Inflammatory Bowel Disease | May 2005 | December 2007 |
| NCT00833170 | Completed | Pediatric Inflammatory Bowel Disease Collaborative Research Group Registry | January 28, 2002 | June 1, 2014 | |
| NCT00849368 | Completed | Phase 1 | Azathioprine & Allopurinol in Inflammatory Bowel Disease Patients | January 2009 | September 2011 |
| NCT03488030 | Completed | A Study to Evaluate Disease Control, Treatment Patterns, Burden of Disease and Quality of Life in Participants With Moderate to Severe Inflammatory Bowel Disease (IBD) | December 12, 2018 | May 31, 2019 | |
| NCT00868660 | Completed | Phase 1 | Healthy Normal Single Ascending Dose and Crohn's Patient Multiple Ascending Dose | January 2009 | February 2010 |
| NCT03338894 | Completed | N/A | A Trial of Yoga in Pediatric Inflammatory Bowel Disease | December 13, 2017 | December 31, 2021 |
| NCT00889161 | Completed | Phase 1 | Curcumin in Pediatric Inflammatory Bowel Disease | May 2009 | June 2010 |
| NCT03264690 | Completed | Study to Observe the Change in Microbiome in Human Derived Sample and the Relation With Clinical Response Before and After the Anti-TNF Treatment in IBD Patients | September 21, 2017 | January 16, 2020 | |
| NCT03043677 | Completed | Ex-vivo Modulatory Effect of Biological Drugs for Inflammatory Bowel Disease on the Mucosa and on Peripheral Blood Mononuclear Cells | April 1, 2016 | May 30, 2018 | |
| NCT02994836 | Completed | Phase 4 | GIS-SUSANTI-TNF-2015 (Anti-TNF Discontinuation ) | April 21, 2017 | December 31, 2022 |
| NCT00972088 | Completed | N/A | Prevalence of Inflammatory Bowel Disease in Patients With Perianal Disease | August 2008 | June 2011 |
| NCT00988273 | Completed | Confocal Endomicroscopy During Endoscopy | October 2009 | December 2014 | |
| NCT01000272 | Completed | Respiratory Tract Inflammation in Children With Inflammatory Bowel Disease (IBD) | December 2009 | October 2012 | |
| NCT02984059 | Completed | Study Assessing Risk Factors for Abdominal Pain in Children With Inflammatory Bowel Disease | October 21, 2015 | August 1, 2018 | |
| NCT01017614 | Completed | Phase 3 | Iron Oligosaccharide in Inflammatory Bowel Disease Subjects With Iron Deficiency Anaemia | October 2009 | August 2012 |
| NCT01032525 | Completed | Monroe County Inflammatory Bowel Disease (IBD) Registry | January 1981 | March 2014 | |
| NCT01034358 | Completed | Phase 4 | Immune Response to the Human Papillomavirus Vaccine in Young Women With Inflammatory Bowel Disease | February 2010 | June 2011 |
| NCT01067547 | Completed | Phase 4 | A Trial of Iron Replacement in Patients With Iron Deficiency. | March 2010 | May 2014 |
| NCT01088646 | Completed | N/A | Evaluation of PillCam® Express Capsule Endoscopy Delivery System | October 2009 | May 2010 |
| NCT01106742 | Completed | Phase 2 | Agaricus Blazei Murill (ABM) in Patients With Inflammatory Bowel Disease (IBD) | March 2009 | July 2011 |
| NCT02922192 | Completed | Incidence of Hospitalizations for Serious Infections in Patients Receiving Biologic Anti-Inflammatories for Rheumatologic, Psoriatic, and Gastrointestinal Conditions: A Descriptive Analysis | January 1, 2012 | June 1, 2020 | |
| NCT02893670 | Completed | N/A | Tailored Transition for IBD Adolescents | March 1, 2017 | September 1, 2022 |
| NCT02862132 | Completed | N/A | Predicting Response to Vedolizumab in Pediatric Inflammatory Bowel Diseases | January 2017 | January 2022 |
| NCT02861118 | Completed | A Retrospective Observational Study to Assess the Impact of Co-morbidities on Treatment Response in Inflammatory Bowel Disease | October 26, 2016 | April 4, 2018 | |
| NCT01213680 | Completed | Phase 1 | Open-label PK Study of Iron Isomaltoside 1000 (Monofer) Administered by 500 mg IV Injection or 1000 mg IV Infusion to Patients With Inflammatory Bowel Disease | February 2012 | November 2012 |
| NCT01221818 | Completed | Phase 1 | A Randomized, Double-Blind, Placebo-Controlled, Ascending Single Dose Study of E6007 in Healthy Subjects | September 2010 | |
| NCT02847884 | Completed | IDeaL Pilot Study - Infliximab Dose to Level: Pilot Study | October 2015 | June 2018 | |
| NCT02846961 | Completed | Anti CT-P13 Antibody in Moderate to Severe Inflammatory Bowel Disease | July 2016 | December 2020 | |
| NCT01253733 | Completed | N/A | MD2Me - Texting to Promote Chronic Disease Management | October 2009 | March 2012 |
| NCT02822235 | Completed | Non-interventional Study of Moderate to Severe Inflammatory Bowel Disease in Brazil | October 11, 2016 | February 19, 2018 | |
| NCT02790281 | Completed | A Study to Investigate Interleukin-6 (IL-6) and IL-6/Soluble IL-6 Receptor (sIL-6R) Complex Levels in Subjects With Active Inflammatory Bowel Disease | December 2014 | August 2015 | |
| NCT01296841 | Completed | Phase 2 | Telemedicine To Provide Inflammatory Bowel Disease Outpatient Care | October 2009 | June 2010 |
| NCT01340872 | Completed | Phase 3 | Safety and Efficacy Study of Oral Ferric Iron To Treat Iron Deficiency Anaemia in Quiescent Ulcerative Colitis (AEGIS-1) | August 2011 | October 2014 |
| NCT01341808 | Completed | Phase 4 | Immunogenicity of Hepatitis A Vaccine in Inflammatory Bowel Disease (IBD) Patients | April 2011 | March 2013 |
| NCT01352221 | Completed | Phase 3 | Safety and Efficacy Study of Oral Ferric Iron To Treat Iron Deficiency Anaemia in Quiescent Crohn's Disease (AEGIS-2) | August 2011 | October 2014 |
| NCT01369329 | Completed | Phase 3 | A Study to Evaluate the Safety and Efficacy of Ustekinumab in Patients With Moderately to Severely Active Crohn's Disease Who Have Failed or Are Intolerant to Tumor Necrosis Factor (TNF) Antagonist Therapy (UNITI-1) | July 2011 | July 2013 |
| NCT01369342 | Completed | Phase 3 | A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease (UNITI-2) | July 2011 | October 2014 |
| NCT01369355 | Completed | Phase 3 | A Study to Evaluate the Safety and Efficacy of Ustekinumab Maintenance Therapy in Patients With Moderately to Severely Active Crohn's Disease (IM-UNITI) | September 13, 2011 | October 1, 2019 |
| NCT01378013 | Completed | SurgicAl Metabolic Phenotyping Longitudinal Evaluation Study | August 2011 | March 2015 | |
| NCT01410435 | Completed | Phase 3 | Safety and Efficacy Extension Study of Iron Isomaltoside 1000 (Monofer®) in Subjects With Inflammatory Bowel Disease | June 2011 | September 2013 |
| NCT01426568 | Completed | N/A | A Trial of Multi-convergent Therapy for Functional Symptoms and Stress in Patients With Inflammatory Bowel Disease | January 2011 | May 2013 |
| NCT02733276 | Completed | N/A | Electroacupuncture vs. Sham Electroacupuncture for Treatment of Fatigue in Patients With Inflammatory Bowel Disease | January 2016 | October 2016 |
| NCT02727959 | Completed | Inflammatory Bowel Disease in South Eastern Norway | January 1, 2017 | December 31, 2019 | |
| NCT01464151 | Completed | Risk Factors for Colorectal Cancer in Patients With Inflammatory Bowel Disease Undergoing Surveillance: a Prospective Cohort Study | July 2011 | May 31, 2021 | |
| NCT01476995 | Completed | Prognostic Indicators as Provided by the EPIC ClearView | September 2010 | June 2011 | |
| NCT01496053 | Completed | Phase 2/Phase 3 | Anti-inflammatory Effect of Agaricus Blazei Murill in Inflammatory Bowel Disease (IBD) | December 2011 | January 2016 |
| NCT02726243 | Completed | Intestinal Microbiota and Colorectal Cancer in Inflammatory Bowel Disease | November 2014 | February 28, 2019 | |
| NCT01531075 | Completed | N/A | Hepatitis B Vaccine in Patients With Inflammatory Bowel Disease | April 2012 | August 2016 |
| NCT01533090 | Completed | N/A | Evaluation of Reduced-volume PEG Bowel Preparation Administered the Same Day of Colonoscopy | April 2010 | November 2010 |
| NCT01536509 | Completed | N/A | Improving Medication Adherence in Pediatric Inflammatory Bowel Disease | February 2012 | May 31, 2016 |
| NCT01557387 | Completed | Real-time Diagnosis of Pseudopolyps During Colonoscopy | September 2011 | February 2013 | |
| NCT02712866 | Completed | Early Biomarkers in Circulating α 4β7 + T Cells to Predict Response to Vedolizumab in Inflamatory Bowel Disease Patients. | January 2017 | February 2019 | |
| NCT01599702 | Completed | Phase 3 | Iron Isomaltoside 1000 (Monofer®) Administered by a High Dosing Regimen in Subjects With Inflammatory Bowel Disease | May 2012 | December 2014 |
| NCT01605175 | Completed | Predictors of Mucosal Healing in Inflammatory Bowel Disease (IBD) Patients Treated With Anti-TNF | May 2012 | September 2014 | |
| NCT01605188 | Completed | Predictors of Non-response and Loss of Response in IBD Patients Treated With Anti-TNF | May 2012 | July 2014 | |
| NCT02707068 | Completed | N/A | Quality Of LIfe Tool for IBD | January 2016 | November 2016 |
| NCT02704026 | Completed | Nutritional Status and Body Composition in Childhood Inflammatory Bowel Disease | July 2015 | January 2017 | |
| NCT02693730 | Completed | Phenotyping IBS: Perceptions and Modulations of Visceral Sensations | January 2016 | June 2021 | |
| NCT02686892 | Completed | An Epidemiological Study of the Incidence of Inflammatory Bowel Disease in Spain | January 2017 | February 28, 2023 | |
| NCT01666327 | Completed | Phase 1 | Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of MT-1303 in Subjects With Inflammatory Bowel Disease | June 2012 | July 2014 |
| NCT01666535 | Completed | N/A | Infliximab IBD Influenza Vaccine Study | September 2012 | August 2013 |
| NCT01676324 | Completed | FOCUS: The Future of Fecal Calprotectin Utility Study for the Diagnosis and Management of Inflammatory Bowel Disease (IBD) | September 2012 | September 2013 | |
| NCT01688557 | Completed | N/A | Trial on Innovative Technologies in Colonoscopy | September 2012 | September 2016 |
| NCT01692743 | Completed | Phase 3 | Telemedicine in Patients With Inflammatory Bowel Disease (TELE-IBD) | September 2012 | September 2016 |
| NCT01708395 | Completed | IBD-OPERA Database, UC Protocol | October 2012 | June 2015 | |
| NCT01718925 | Completed | 25-hydroxyvitamin D and Fatigue: The VITALITY Study | October 2012 | December 2014 | |
| NCT01720368 | Completed | OPERA Database - Crohn's Protocol | October 2012 | June 2015 | |
| NCT01756963 | Completed | Diet and Disease Activity in Patients With Inflammatory Bowel Disease | November 2012 | July 2018 | |
| NCT01757964 | Completed | Phase 1 | Bacteriotherapy in Pediatric Inflammatory Bowel Disease | December 2012 | January 2015 |
| NCT02680756 | Completed | Phase 3 | Safety and Efficacy Study of Oral Ferric Maltol Compared to Intravenous Iron To Treat Iron Deficiency Anaemia in IBD | January 2016 | January 2019 |
| NCT02624037 | Completed | N/A | Precision IFX: Using a Dashboard to Individualize Infliximab Dosage | January 2015 | October 21, 2020 |
| NCT01781481 | Completed | The Pediatric Intermed: A New Clinical Decision Making Tool | April 2010 | August 2014 | |
| NCT01787825 | Completed | N/A | Comparison of Capso Vision SV-1 to PillCam SB2 in the Evaluation of Subjects With Suspected Small Bowel Disease | May 2012 | February 2016 |
| NCT02620514 | Completed | N/A | Medication Adherence in Patients With Inflammatory Bowel Disease (IBD) | June 2015 | November 1, 2016 |
| NCT02614014 | Completed | N/A | Stress and Personality Profiles in IBD | June 2014 | June 2017 |
| NCT01809275 | Completed | Phase 1/Phase 2 | Safety and Treatment Effect of QBECO in Moderate to Severe Crohn's Disease | March 2013 | July 2016 |
| NCT02612103 | Completed | Biomarkers in Inflammatory Bowel Diseases | November 2015 | June 2019 | |
| NCT01813500 | Completed | Host Immune Response to Clostridium Difficile Infection in Inflammatory Bowel Disease Patients | October 2011 | April 2016 | |
| NCT02588222 | Completed | GRINCH: Groningen Initiative on Reference Intervals in Children | June 2015 | May 2016 | |
| NCT01852760 | Completed | Assessment of Disease Activity in Ulcerative Colitis by Endoscopic Ultrasound | September 2013 | July 2015 | |
| NCT02563132 | Completed | N/A | Carbon Dioxide Insufflation Colonoscopy in IBD Patients | October 2015 | May 2016 |
| NCT01854242 | Completed | Study of the Relationship Between Glycogen Storage Disease Type Ia and Inflammatory Bowel Disease | November 2013 | October 2014 | |
| NCT01860651 | Completed | N/A | Web-based Monitoring in Children and Adolescents With Inflammatory Bowel Disease | September 2013 | May 2017 |
| NCT01861288 | Completed | Deep Endoscopic Remission Assessed by a Surrogate Biomarker in Patients With Inflammatory Bowel Disease | November 1, 2013 | February 28, 2018 | |
| NCT01880606 | Completed | Endomicroscopy in Primary Sclerosing Cholangitis Related Inflammatory Bowel Disease Surveillance | August 2011 | June 2014 | |
| NCT01896635 | Completed | Phase 2 | Faecal Microbiota Transplantation in Ulcerative Colitis | November 2013 | August 2016 |
| NCT01918813 | Completed | N/A | Risk of Methicillin-resistant S.Aureus (MRSA) Infections in MRSA Carrier Under Introduction of Rapid MRSA Screening | November 2009 | February 2012 |
| NCT01933867 | Completed | N/A | Water-aided Colonoscopy in Inflammatory Bowel Disease Patients | September 2013 | August 2014 |
| NCT01934088 | Completed | Phase 4 | Satisfaction With Nurse Administered Propofol Sedation vs. Midazolam With Fentanyl Sedation for Endoscopy | January 2014 | September 2015 |
| NCT01966744 | Completed | Self-Management Assistance for Recommended Treatment (SMART) Portal | July 2013 | June 2016 | |
| NCT01971814 | Completed | Phase 1 | Early Serum Infliximab Levels in Severe Ulcerative Colitis. | November 2013 | January 2015 |
| NCT01981616 | Completed | Phase 1 | Immune Response to Systemic and Mucosal Antigenic Challenge in the Presence of Vedolizumab | September 2011 | July 2012 |
| NCT01984879 | Completed | Vaccination Status, Knowledge and Attitude in Korean Patients With IBD | November 2013 | March 2016 | |
| NCT02003859 | Completed | Predictive Value of pCLE Findings in Pediatric IBD | November 2010 | November 2014 | |
| NCT02543762 | Completed | Usefulness of Chromoendoscopy for the Early Detection of Colorectal Cancer Associated With Inflammatory Bowel Disease | February 2012 | May 2015 | |
| NCT02048137 | Completed | Phase 2 | Transcranial Direct Current Stimulation to Reduce Chronic Pain in Patients With Chronic Inflammatory Bowel Diseases | January 2014 | |
| NCT02065089 | Completed | N/A | Development of 'Emma'--a Pediatric IBD Quiz | February 6, 2014 | January 5, 2017 |
| NCT02543021 | Completed | N/A | Virtual Chromoendoscopy for Colitis Surveillance: A Feasibility Study | November 1, 2015 | February 1, 2018 |
| NCT02073526 | Completed | Anti-TNF-alpha Trough Level Measurements in Inflammatory Bowel Disease | May 2013 | November 2016 | |
| NCT02538679 | Completed | N/A | A Comparison of Ultrasound Guided Transversus Abdominis Plane Nerve Block Techniques | August 7, 2015 | April 30, 2017 |
| NCT02085083 | Completed | N/A | Improving OutcoMes in the Pediatric to Adult Care Transition in Inflammatory Bowel Disease | July 2014 | December 2017 |
| NCT02098798 | Completed | Comparison of Surveillance Colonoscopy Techniques in Patients With IBD | March 2014 | August 2016 | |
| NCT02113111 | Completed | Effects of Fasting on Self Efficacy | April 2014 | September 2015 | |
| NCT02526251 | Completed | Does the Microbiome in IBD Change Alongside Special Treatment Scenarios? | August 2015 | September 2017 | |
| NCT02129972 | Completed | N/A | Colon Capsule Endoscopy in Children | April 2014 | April 2018 |
| NCT02135289 | Completed | The Role of IGRA in Screening and Monitoring for TB During Anti TNF Therapy in Patients With IMID | March 2012 | July 31, 2019 | |
| NCT02136745 | Completed | N/A | Effects of Relaxation Response Mind-body Intervention in Patients With IBS and IBD | May 2009 | July 2011 |
| NCT02503696 | Completed | Sample Collection Study to Evaluate DNA Markers in Subjects With Inflammatory Bowel Disease (IBD) | September 2014 | June 2016 | |
| NCT02152241 | Completed | Long-term Functional Outcome of Children With Inflammatory Bowel Disease | June 2014 | June 2016 | |
| NCT02161640 | Completed | Vascular Dysfunction in Paediatric IBD | September 2014 | January 2017 | |
| NCT02162862 | Completed | Phase 4 | Treating Disrupted Sleep in Individuals With Inflammatory Bowel Disease | July 2013 | June 30, 2016 |
| NCT02173002 | Completed | N/A | Integrated Care for Inflammatory Bowel Disease Patients in the Netherlands With the Novel Telemedicine Tool myIBDcoach: a Randomized Controlled Trial | July 2014 | July 2016 |
| NCT02181153 | Completed | N/A | Genetic, Serological Fecal and Clinical Markers in Siblings of Children With Inflammatory Bowel Disease | December 2013 | May 2016 |
| NCT02197780 | Completed | Head-to-head Comparison of Two Fecal Biomarkers to Screen Children for IBD | September 2014 | April 2017 | |
| NCT02222584 | Completed | The Effects of Physical Activity on Patients With Inflammatory Bowel Disease | July 2014 | February 2018 | |
| NCT02502552 | Completed | Study of Anti-glycan Antibodies Stability in Saint-Etienne IBD Cohort | November 2013 | October 2015 | |
| NCT02487238 | Completed | Phase 1 | Pediatric FEcal Microbiota Transplant for Ulcerative Colitis | November 2015 | December 2018 |
| NCT02248337 | Completed | Phase 4 | Low Volume Colon Preparation for IBD | March 2013 | March 2014 |
| NCT02255019 | Completed | MRI in Patients With Inflammatory Bowel Disease | May 2011 | June 2013 | |
| NCT02263703 | Completed | Phase 3 | Immunogenicity of HPV Vaccine in Immunosuppressed Children | May 2007 | December 2016 |
| NCT02464020 | Completed | Phase 1 | A Pilot Study to Characterize Bile Acid Metabolism and Dysbiosis in Primary Sclerosing Cholangitis | July 2015 | December 1, 2018 |
| NCT02322008 | Completed | Anti-TNF Therapy in Danish Patients With Inflammatory Bowel Diseases in Clinical Practice | September 2009 | March 2011 | |
| NCT02322307 | Completed | N/A | Trial on Impact of HealthPROMISE Mobile App on Inflammatory Bowel Disease Care and Quality of Life | February 2015 | January 20, 2020 |
| NCT02460705 | Completed | Early Phase 1 | Fecal Microbiota Transplant for Inflammatory Bowel Disease | June 2015 | November 4, 2017 |
| NCT02453880 | Completed | N/A | Web-based CBT for Symptoms of Mild-to-Moderate Anxiety and Depression in Youth With Chronic Illness | January 2014 | August 2015 |
| NCT02341742 | Completed | Physical Activity and Bone Mineral Density in Children and Adolescents With Chronic Inflammatory Bowel Disease | October 2014 | December 2017 | |
| NCT02350920 | Completed | N/A | Acceptance and Commitment Therapy (ACT) in Inflammatory Bowel Disease | June 2015 | March 2017 |
| NCT02351635 | Completed | BÜHLMANN fCAL™ ELISA - Aid in Differentiation of IBD From IBS | January 2015 | April 2018 | |
| NCT02453776 | Completed | Phase 4 | Precision Dosing of Infliximab Versus Conventional Dosing of Infliximab | May 2015 | December 2018 |
| NCT02438410 | Completed | Correlation of Infliximab Levels With Outcomes in Ulcerative Colitis | May 2015 | December 4, 2019 | |
| NCT02423512 | Completed | The Impact of Anti-TNF Exposure on Vedolizumab Effectiveness | June 2015 | June 13, 2017 | |
| NCT02433470 | Completed | Phase 2 | Association of Functional Changes in the Brain and the Perception of Pain in Patients With Chronic Inflammatory Bowel Diseases (IBD) | April 2015 | |
| NCT00035074 | Completed | N/A | A Pharmacokinetic Study to Determine the Oral Bioavailability of Methotrexate in Patients With Inflammatory Bowel Disease | ||
| NCT00040521 | Completed | Phase 2 | Study Evaluating rhIL-11 in Active Crohn's Disease | April 2002 | October 2003 |
| NCT05638347 | Completed | Phase 1 | A Trial of HRS-7085 Tablet in Healthy Participants With and Without Food Effect. | December 5, 2022 | March 16, 2023 |
| NCT01171872 | Enrolling by invitation | Gene Expression in Inflammatory Bowel Disease | November 1999 | December 2032 | |
| NCT03983837 | Enrolling by invitation | Phase 2 | Elemental Diet for Treatment of Inflammatory Bowel Disease in Patients With Chronic Granulomatous Disease | June 23, 2021 | June 23, 2026 |
| NCT04456517 | Enrolling by invitation | Phase 2 | Reduce Crohn's-Associated Diarrhea With Sodium Channel Therapy | October 18, 2022 | December 2025 |
| NCT06175949 | Not yet recruiting | Phase 1 | A Randomized, Double-Blind, Dose-Escalation, Placebo-Controlled Phase I Clinical Trial Investigating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Oral Doses of HRS-7085 Tablets in Healthy Subjects, With Assessment of Food Effects | December 2023 | July 2024 |
| NCT06405503 | Not yet recruiting | Impact of Primary Language on Treatment and Outcomes in Inflammatory Bowel Disease | June 1, 2024 | June 30, 2025 | |
| NCT05659953 | Not yet recruiting | Phase 1 | LMT503 First-in-human SAD, MAD, and FE Study | April 1, 2024 | March 1, 2025 |
| NCT01266538 | Not yet recruiting | Inflammatory Bowel Disease(IBD)Database | January 2011 | December 2026 | |
| NCT01169194 | Recruiting | Multi-Center African-American Inflammatory Bowel Disease Study (MAAIS) | June 2003 | August 2027 | |
| NCT02636517 | Recruiting | Phase 1 | Fecal Microbiome Transplant | December 2015 | December 2025 |
| NCT04331639 | Recruiting | Phase 2 | High Dose Interval Vitamin D Supplementation in Patients With Inflammatory Bowel Disease Receiving Biologic Therapy | November 1, 2020 | September 2024 |
| NCT05394272 | Recruiting | N/A | Efficacy of Energy Therapy in the Management of Chronic Pain Medical Condition in Children and Adolescents. | June 15, 2022 | June 16, 2025 |
| NCT06001450 | Recruiting | Pregnant Women With and Without Crohns Disease to Explore the Role of Plastics and Toxins in Intestinal Inflammation | August 30, 2023 | October 23, 2024 | |
| NCT05633771 | Recruiting | Observational Study, to Assess Treatment Retention of an Adalimumab Biosimilar (Hyrimoz®) in IBD Patients in Real Life Setting | February 16, 2023 | December 2026 | |
| NCT04508088 | Recruiting | Skeletal Health and Bone Marrow Composition in Newly Diagnosed Adolescents With Crohn Disease | September 10, 2020 | December 2024 | |
| NCT04751396 | Recruiting | Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors | April 20, 2022 | April 15, 2025 | |
| NCT05973500 | Recruiting | N/A | Effect of Mediterranean Diet in Inflammatory Bowel Disease | September 1, 2023 | August 1, 2028 |
| NCT00001184 | Recruiting | Immune Regulation in Ulcerative Colitis or Crohn s Disease | August 7, 1998 | ||
| NCT03615690 | Recruiting | N/A | The Influence of a Fasting Mimicking Diet on Ulcerative Colitis | December 15, 2020 | December 2025 |
| NCT06321887 | Recruiting | Phase 3 | EffiCacy and sAfEty of Low doSe orAl iRon for Anaemia in IBD | October 20, 2023 | October 1, 2025 |
| NCT01793831 | Recruiting | N/A | Standardized Fecal Microbiota Transplantation for Crohn&Apos;s Diseases | February 2013 | December 2025 |
| NCT02614911 | Recruiting | Characterization of Phenotype and Genotype of Early Onset Enteropathies | June 16, 2014 | June 15, 2054 | |
| NCT01790061 | Recruiting | Phase 2/Phase 3 | Standardized Fecal Microbiota Transplantation for Ulcerative Colitis | February 2013 | December 2025 |
| NCT01650311 | Recruiting | Investigating Serotonin Signalling in IBD Patients | July 2012 | May 2025 | |
| NCT03816345 | Recruiting | Phase 1 | Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer | July 16, 2019 | August 31, 2024 |
| NCT05071742 | Recruiting | Correlation of Genetic Susceptibility Genes to Inflammatory Bowel Disease in Chinese Han Population | November 25, 2021 | December 31, 2024 | |
| NCT03913962 | Recruiting | N/A | Health and Exercise Response in Children With Chronic and Auto-immune Pathologies | May 2, 2019 | December 31, 2028 |
| NCT06346288 | Recruiting | Phase 4 | A Study to Assess the Concentrations of Risankizumab in the Breast Milk of Adult Lactating Women With Inflammatory Bowel Disease | May 6, 2024 | May 24, 2025 |
| NCT00904878 | Recruiting | A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women With Inflammatory Bowel Disease | August 2007 | June 2025 | |
| NCT05579392 | Recruiting | N/A | A Randomized Crossover Trial of Bright Light Therapy in Crohn's Disease on Intestinal Barrier Homeostasis | September 22, 2022 | May 31, 2025 |
| NCT05002166 | Recruiting | Clinical Characteristics and Risk Factors of Children Suffering From Inflammatory Bowel Diseases At Assiut University Children Hospital | August 5, 2021 | July 20, 2027 | |
| NCT04060303 | Recruiting | Phase 3 | ENhanced Recovery in CHildren Undergoing Surgery | July 1, 2020 | December 31, 2024 |
| NCT02847052 | Terminated | Study of the Role of Soluble Inhibitor of Interleukin 22, Interleukin 22 Binding Protein (IL-22BP), in Chronic Inflammatory Bowel Disease | August 2014 | March 16, 2022 | |
| NCT02391012 | Terminated | Phase 1 | Fecal Transplantation for Inflammatory Bowel Disease | April 2015 | July 2016 |
| NCT01140802 | Terminated | Gut Microbiota in the Healthy Population, Inflammatory Bowel Disease Patients, and Their Relatives | April 2010 | January 2015 | |
| NCT02481687 | Terminated | The Value of I-Scan and Confocal Laser Endomicroscopy for the Assessment of Chronic Inflammatory Bowel Disease | June 2015 | June 2017 | |
| NCT01009281 | Terminated | Phase 2 | An Open Label Safety and Tolerability Study of AIN457 in Patients With Moderate to Severe Crohn's Disease | October 30, 2009 | August 19, 2010 |
| NCT00936585 | Terminated | N/A | NIH Substudy of AIN457 (Anti-IL-17 Monoclonal Antibody) for Treatment of Moderate to Severe Crohn's Disease | July 2009 | February 2011 |
| NCT02413047 | Terminated | N/A | Evaluate if Response to Infliximab or Adalimumab May be Regained With an Immunomodulator | May 2015 | February 2018 |
| NCT03201445 | Terminated | Phase 2 | Study to Evaluate the Testicular Safety of Filgotinib in Adult Males With Moderately to Severely Active Inflammatory Bowel Disease | July 11, 2017 | October 24, 2023 |
| NCT01853241 | Terminated | Prospective Randomized Trial of Anterograde Single Balloon Versus Spirus Enteroscopy | May 2010 | January 2011 | |
| NCT01851343 | Terminated | Phase 1 | Bone Marrow Stromal Cells for Inflammatory Bowel Diseases | January 27, 2013 | July 12, 2017 |
| NCT00855907 | Terminated | Fatty Liver in Inflammatory Bowel Disease (IBD) Patients | March 2009 | March 2011 | |
| NCT00805285 | Terminated | Phase 2 | The Use of Oral Budesonide and Rectal Hydrocortisone for the Treatment of Active Ulcerative Colitis | October 2008 | March 2010 |
| NCT02392286 | Terminated | Phase 4 | Corticosteroid Dosage for Crohn's Disease Flare | March 2015 | December 19, 2016 |
| NCT01587872 | Terminated | N/A | Double-balloon Colonoscopy to Increase Colonoscopy Completion Rate | October 2011 | April 2014 |
| NCT00621257 | Terminated | N/A | Vitamin D Levels in Children With IBD | January 2008 | March 2011 |
| NCT00591669 | Terminated | N/A | Non-invasive Imaging of GI Inflammation Using Microbubble Contrast Enhanced Ultrasonography | May 2006 | December 2010 |
| NCT04102163 | Terminated | Health-Related Quality of Life in Crohn's Disease Participants With Complex Perianal Fistula Before and After Treatment | January 26, 2021 | May 26, 2021 | |
| NCT00423345 | Terminated | Colon Investigation - Factors Determining Choice of Procedure | October 2006 | May 2015 | |
| NCT00038922 | Terminated | Phase 1 | Study Evaluating rhIL-11 in Left-Sided Ulcerative Colitis | ||
| NCT01428843 | Terminated | Phase 3 | Comparison of Ferrisat vs Placebo in Anemia Associated to Inflammatory Bowel Disease During Anti-TNF Therapy | January 2011 | December 2014 |
| NCT02128503 | Terminated | N/A | Prevalence and Clinical Course of Chronic Hep B Infection in IBD and Rheumatologic Disease | February 2013 | October 16, 2015 |
| NCT00061282 | Terminated | Phase 1/Phase 2 | Clotrimazole Enemas for Pouchitis in Children and Adults | September 30, 2002 | December 1, 2020 |
| NCT02426762 | Unknown status | Phase 2 | Quick Skin Sealant in Closure of Surgical Wound After Laparoscopic Surgery | February 2015 | October 2015 |
| NCT02453607 | Unknown status | The Impact of 6MP Metabolite Levels on Infliximab Pharmacokinetics and Anti-infliximab Antibodies in Crohn's Disease | November 17, 2014 | June 30, 2020 | |
| NCT02383953 | Unknown status | SSAT 054: Non Genetic Factors in the Pathogenesis of IBD in Twins | May 2015 | October 2017 | |
| NCT02335281 | Unknown status | Phase 2 | Standardized Fecal Microbiota Transplantation for Inflammatory Bowel Disease | January 2015 | December 2017 |
| NCT02330458 | Unknown status | The Role of Small Bowel Ultrasound in Initiation of Infliximab in Crohn's Disease Patients | July 2014 | May 2018 | |
| NCT02463916 | Unknown status | Phase 2 | A Trial to Determine the Effects of Exercise in Inflammatory Bowel Disease and Rheumatoid Arthritis | March 2015 | June 2016 |
| NCT02275676 | Unknown status | Resting Energy Expenditure and Nutritional Status in IBD | September 2014 | September 2016 | |
| NCT02478944 | Unknown status | N/A | Esophageal Motility Disease Screening in Patient With Suspicion or Diagnosis of IBD | October 2014 | January 2017 |
| NCT02247622 | Unknown status | Telomere Length and Other Parameters of Telomere Dysfunction in PSC and Colitis | February 2012 | September 2014 | |
| NCT02492555 | Unknown status | N/A | Is Relapse Rate Reduced by Home Monitoring of IBD Patients Tightly or on Demand by FC and Disease Activity? | July 2015 | November 2017 |
| NCT02245594 | Unknown status | GI Symptoms and Sleep Disturbances in Patients With Quiescent Crohns Disease | October 2014 | October 2015 | |
| NCT02517151 | Unknown status | Phase 2 | Iron Supplementation in Inflammatory Bowel Disease (IBD) Patients With Chronic Fatigue | October 2014 | December 2016 |
| NCT02079441 | Unknown status | Immune Function in Offsprings of Females With Inflammatory Bowel Disease (IBD) Treated With Anti-TNF Medications During Pregnancy | March 2014 | ||
| NCT02066272 | Unknown status | Safety of Anti-tumor Necrosis Factor (TNF) Monoclonal Antibodies in Inflammatory Bowel Disease | January 2014 | December 2016 | |
| NCT02016469 | Unknown status | N/A | Effects of Pectin on Flora Intestinal Colonization and Maintenance After Fecal Transplantation | December 2013 | February 2016 |
| NCT02598414 | Unknown status | Phase 2/Phase 3 | The Role of Indocyanine Green (ICG) Fluorescence Imaging on Anastomotic Leak in Robotic Colorectal Surgery | November 2015 | December 2017 |
| NCT02603185 | Unknown status | Phase 1 | PhaseⅠFirst-in-Human Study of Hemay007 in Healthy Volunteers | January 9, 2017 | March 2018 |
| NCT01771224 | Unknown status | Early Phase 1 | Effect of FAn-7 in UC Activity | January 2013 | December 2014 |
| NCT01758926 | Unknown status | Association Between Inflammatory Activities and Gap Density | December 2012 | June 2013 | |
| NCT02693340 | Unknown status | Evolution of Lymphocyte Populations Under Biotherapy in Inflammatory Bowel Disease | February 2016 | March 2020 | |
| NCT01632488 | Unknown status | Assessment of Small Intestinal Bowel Epithelial Gaps in Irritable Bowel Syndrome | June 2012 | December 2012 | |
| NCT01626963 | Unknown status | Phase 1/Phase 2 | Single-port Versus Conventional Laparoscopic Colorectal Surgery | January 2014 | December 2016 |
| NCT02709434 | Unknown status | N/A | Fatigue Management in Quiescent IBD | December 2016 | March 2017 |
| NCT02774057 | Unknown status | Phase 4 | Trial of Captafer® vs. Oral Iron Sulfate in the Treatment of Iron Deficiency Anemia in Patients With IBD | March 2016 | August 2017 |
| NCT02828748 | Unknown status | N/A | Cytokine Production of Colonic Tissue From IBD Patients | December 2016 | September 2018 |
| NCT02841657 | Unknown status | 3D Laparoscopy Versus 2D Laparoscopy | January 2016 | October 2017 | |
| NCT01244386 | Unknown status | Low-dose CT Using Iterative Reconstruction in Patients With Inflammatory Bowel Disease | June 2010 | December 2011 | |
| NCT01237847 | Unknown status | N/A | A Brief Intervention to Improve Adherence in Teens With Inflammatory Bowel Disease | July 2010 | July 2013 |
| NCT02849821 | Unknown status | N/A | The Altitude Inflammatory Bowel Disease Study | May 2014 | December 2016 |
| NCT02861053 | Unknown status | N/A | Inflammatory Bowel Disease : Could a Regular Physical Activity Reduce Patients Fatigue ? | September 2016 | April 2018 |
| NCT01121796 | Unknown status | N/A | Influence of Vitamin D on Inflammatory Bowel Disease Remission | June 2010 | |
| NCT02950779 | Unknown status | Assessment of Handgrip Strength in Adults With Inflammatory Bowel Disease | October 2016 | October 2017 | |
| NCT00915044 | Unknown status | Interactions Between Immune Cells of Intestinal Mucosa or Peripheral Blood With the Extracellular Matrix in Inflammatory Bowel Disease (IBD) | July 2007 | ||
| NCT03239704 | Unknown status | N/A | Improving Outcomes Among Urgent Care Clinic Patients With Inflammatory Bowel Disease | December 1, 2018 | December 1, 2020 |
| NCT00883077 | Unknown status | Assessment of Colonic Permeability by Confocal Laser Endomicroscopy | April 2009 | December 2009 | |
| NCT03414580 | Unknown status | Analysis of Volatile Organic Compounds in the Exhaled Air in Inflammatory Bowel Disease | February 20, 2018 | June 1, 2021 | |
| NCT03744130 | Unknown status | N/A | Contrast-enhanced Bowel Ultrasound in Making a Diagnosis and Follow-up of Patients With Inflammatory Bowel Disease | January 10, 2018 | June 30, 2021 |
| NCT03852745 | Unknown status | N/A | Managing Stress With Inflammatory Bowel Disease | April 18, 2019 | December 31, 2022 |
| NCT04349943 | Unknown status | N/A | Effect of Standardized Nutritional Therapy on Clinical Prognosis and Cost-effectiveness of Inflammatory Bowel Disease | November 26, 2019 | December 30, 2021 |
| NCT04492267 | Unknown status | Inflammatory Bowel Disease (IBD) and Covid-19 Infection | July 7, 2020 | January 7, 2021 | |
| NCT04507932 | Unknown status | Early Phase 1 | Characterizing Inflammatory Bowel Disease With 68Ga-FAPI PET/CT | August 1, 2020 | December 1, 2022 |
| NCT04924686 | Unknown status | Changes of Muramyl Dipeptide in Intestinal and Extra-intestinal Diseases | May 10, 2020 | August 15, 2023 | |
| NCT00291681 | Unknown status | Differences in Human Germinal Center B Cell Selection Revealed by Analysis of IgVH Gene Hypermutation and Lineage Trees in Inflammatory Bowel Disease | September 2005 | ||
| NCT00783575 | Withdrawn | Genetic Markers as Predictors of Phenotypes in Pediatric Onset Crohn's Disease | October 2002 | January 2015 | |
| NCT02470663 | Withdrawn | N/A | Bone Density in Children With IBD Treated With Amorphous Calcium or Commercial Crystalline Calcium | July 2015 | December 2017 |
| NCT03414788 | Withdrawn | Phase 1 | Distribution of a Single IV Dose Of [124I]-Pf 06687234 and Pf 06687234 Assessed With PET-CT Imaging In Moderate To Severe Ulcerative Colitis and Crohn's Disease | December 7, 2020 | February 1, 2022 |
| NCT03278912 | Withdrawn | Natural History of Intestinal Inflammation in People With Primary Immune Dysregulations | September 8, 2023 | September 8, 2023 | |
| NCT03035058 | Withdrawn | Phase 3 | Efficacy and Safety of Vedolizumab Intravenous (IV) in the Treatment of Primary Sclerosing Cholangitis in Subjects With Underlying Inflammatory Bowel Disease | February 2017 | January 2021 |
| NCT01293656 | Withdrawn | Study of Participants With Crohn's Disease and Ulcerative Colitis in Eastern Europe, Middle East, and North Africa (P08166) | August 2011 | July 2012 | |
| NCT05652491 | Withdrawn | The Role of Gut Microbiome in Predicting Comorbidities and Complications in Children With Inflammatory Bowel Disease | December 9, 2022 | May 30, 2023 | |
| NCT02771457 | Withdrawn | Phase 3 | Managing Infliximab Reinduction After Temporary Discontinuation of Drug | July 2016 | July 2019 |
| NCT02740309 | Withdrawn | N/A | Integrated Behavioral Health Innovations in Childhood Chronic Illness Care Delivery Systems | April 2016 | March 2018 |
| NCT01438372 | Withdrawn | Phase 2 | IV Iron Sucrose vs Oral FeSO4 in Treating IDA in Pediatric IBD | November 2011 | March 2012 |
| NCT01524120 | Withdrawn | Endoscopy and Endomicroscopy for Assessment of Mucosal Healing in Inflammatory Bowel Disease (IBD) | April 2012 | ||
| NCT01640496 | Withdrawn | N/A | Vitamin D Treatment in Ulcerative Colitis | July 2012 | December 2014 |
| NCT01810185 | Withdrawn | Phase 2 | Low Dose Naltrexone in Symptomatic Inflammatory Bowel Disease | March 2013 | March 2014 |
| NCT02139709 | Withdrawn | Phase 1 | Milk-derived Gangliosides for Inflammatory Bowel Disease | January 2007 | August 2015 |
| NCT04017637 | Withdrawn | N/A | Resistance Training Intervention to Promote Lean Mass in Youth With IBD | March 6, 2020 | March 6, 2020 |
- Disase is a (Disease Ontology)
- DOID:5295
- Cross Reference ID (Disease Ontology)
- EFO:0003767
- Cross Reference ID (Disease Ontology)
- KEGG:05321
- Cross Reference ID (Disease Ontology)
- MESH:D015212
- Cross Reference ID (Disease Ontology)
- MIM:PS266600
- Cross Reference ID (Disease Ontology)
- NCI:C3138
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:155759008
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0021390
- OMIM Phenotype Series Number (OMIM)
- PS266600